نتایج جستجو برای: artesunate

تعداد نتایج: 1720  

Journal: :Bulletin of the World Health Organization 1994
J Karbwang K Na-Bangchang A Thanavibul D Bunnag T Chongsuphajaisiddhi T Harinasuta

In Thailand Plasmodium falciparum malaria is highly resistant to available antimalarials. Investigations on the efficacy of existing antimalarials and of alternative drugs are urgently needed. Artesunate has been shown to be effective against falciparum malaria, but is associated with a high recrudescence rate. We have carried out a comparative clinical trial of the standard regimen of quinine ...

2015
Stephanie D. Kovacs Marcus J. Rijken Andy Stergachis

Severe malaria in pregnancy is a large contributor to maternal morbidity and mortality. Intravenous quinine has traditionally been the treatment drug of choice for severe malaria in pregnancy. However, recent randomized clinical trials (RCTs) indicate that intravenous artesunate is more efficacious for treating severe malaria, resulting in changes to the World Health Organization (WHO) treatmen...

2010
Hyang-Ae Lee Ki-Suk Kim Eun-Joo Kim

Artesunate, a semi-synthetic derivative of artemisinin, is used primarily as a treatment for malaria. Its effects on the central nervous system, general behavior, and cardiovascular, respiratory, and other organ systems were studied using mice, rats, guinea pigs, and dogs. Artesunate was administered orally to mice at doses of 125, 250, and 500 mg/kg and to rats and guinea pigs at 100, 200, and...

Journal: :Antimicrobial agents and chemotherapy 1999
N X Khanh P J de Vries L D Ha C J van Boxtel R Koopmans P A Kager

Six patients with uncomplicated falciparum malaria received artesunate for 5 days. Plasma concentrations of artesunate and dihydroartemisinin were determined by high-performance liquid chromatography with electrochemical detection. The concentrations of dihydroartemisinin in plasma 2 h after a dose showed a time-dependent decline. Concentrations of artesunate in plasma especially after the last...

Journal: :The American journal of tropical medicine and hygiene 2008
Tran Tinh Hien Ng Thanh Truong Nguyen Hoang Minh Hoang Dinh Dat Nguyen Thi Dung Nguyen Thi Hue Tran Kim Dung Phung Quoc Tuan James I Campbell Jeremy J Farrar Jeremy N Day

Human fascioliasis caused by Fasciola hepatica or Fasciola gigantica is an increasing global problem. The mainstay of current treatment is triclabendazole, but resistance in animals has been described, and it is not available in many countries. The antimalarial artesunate has an excellent safety profile, and there is increasing evidence of its efficacy against other parasites both in vitro and ...

Journal: :Journal of infection in developing countries 2014
Tajeldin M Abdallah Khalid A Elmardi Asama H Elhassan Mona B Omer Mousab S Elhag Mohamed A Desogi Mohammed F Siddig Ishag Adam

INTRODUCTION There is a need to investigate the treatment (artesunate and quinine) of severe malaria, as this will influence the outcome of morbidity and the mortality of the disease. METHODOLOGY An open randomized trial conducted at Kassala, Sudan. Patients with severe P. falciparum malaria were randomly assigned to either intravenous artesunate at 2.4 mg/kg at 0, 12, and 24 hours, then dail...

2012
Fatai A. Fehintola Kimberly K. Scarsi Qing Ma Sunil Parikh Gene D. Morse Babafemi Taiwo Ibrahim Tope Akinola Isaac F. Adewole Niklas Lindegardh Aphiradee Phakderaj Oladosu Ojengbede Robert L. Murphy Olusegun O. Akinyinka Francesca T. Aweeka

Background. Nevirapine- (NVP-) based antiretroviral therapy (ART) and artesunate-amodiaquine are frequently coprescribed in areas of HIV and malaria endemicity. We explored the impact of this practice on artesunate and dihydroartemisinin pharmacokinetics. Methods. We conducted a parallel-group pharmacokinetic comparison between HIV-infected patients receiving NVP-based ART (n = 10) and ART-naiv...

Journal: :Talanta 2014
Myra T Koesdjojo Yuanyuan Wu Anukul Boonloed Elizabeth M Dunfield Vincent T Remcho

With the emergence of artesunate antimalarial counterfeiting in Southeast Asia and sub-Saharan Africa, we present the production of a rapid, inexpensive and simple colorimetric-based testing kit for the detection of counterfeit artesunate in order to preserve life and prevent the development of multi-drug resistant malaria. The kit works based on paper microfluidics which offer several advantag...

Journal: :PLoS ONE 2007
Tanilu Grande Andrea Bernasconi Annette Erhart Dioni Gamboa Martin Casapia Christopher Delgado Kathy Torres Caterina Fanello Alejandro Llanos-Cuentas Umberto D'Alessandro

BACKGROUND Multi-drug resistant falciparum malaria is an important health problem in the Peruvian Amazon region. We carried out a randomised open label clinical trial comparing mefloquine-artesunate, the current first line treatment in this region, with dihydroartemisinin-piperaquine. METHODS AND FINDINGS Between July 2003 and July 2005, 522 patients with P. falciparum uncomplicated malaria w...

2015
Stéphane Jauréguiberry Marc Thellier Papa Alioune Ndour Flavie Ader Camille Roussel Romain Sonneville Julien Mayaux Sophie Matheron Adela Angoulvant Benjamin Wyplosz Christophe Rapp Thierry Pistone Bénédicte Lebrun-Vignes Eric Kendjo Martin Danis Sandrine Houzé François Bricaire Dominique Mazier Pierre Buffet Eric Caumes

Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in ≈20% of travelers who receive artesunate, ≈60% of whom require transfusion. This finding could discourage physicians from using artesunate. We prospectively evaluated a cohort of 123 patients in France who had severe imported malaria that was treated with artesunate; our e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید